{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:57:31Z","timestamp":1790384251918,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd006034.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000}}],"reference-count":74,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006034.pub3","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T07:57:23Z","timestamp":1661500643000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine-device use"],"prefix":"10.1002","volume":"2022","author":[{"given":"Karen","family":"Christelle","sequence":"additional","affiliation":[{"name":"Department of Family Medicine; Universiti Sains Malaysia; Kubang Kerian Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd N","family":"Norhayati","sequence":"additional","affiliation":[{"name":"Department of Family Medicine; Universiti Sains Malaysia; Kubang Kerian Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharifah Halimah","family":"Jaafar","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology; Regency Specialist Hospital; Johor Bahru Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD006034.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/13625187.2018.1515349","article-title":"Oral micronised flavonoids versus tranexamic acid for treatment of heavy menstrual bleeding secondary to copper IUD use: a randomised double-blind clinical trial","volume":"23","author":"Alanwar","year":"2018","journal-title":"European Journal of Contraception & Reproductive Health Care"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0002-9378(79)90844-5","article-title":"Naproxen sodium in uterine pain following intrauterine contraceptive device insertion","volume":"134","author":"Buttram","year":"1979","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0003|cit3","first-page":"74","article-title":"Reduction by naproxen of excessive menstrual bleeding in women using intrauterine devices","volume":"57","author":"Davies","year":"1981","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ijgo.13068","article-title":"A randomized controlled pilot study of ulipristal acetate for abnormal bleeding among women using the 52-mg levonorgestrel intrauterine system","volume":"149","author":"Fava","year":"2020","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0002-9378(79)90712-9","article-title":"The influence of acetylsalicylic acid and paracetamol on menstrual blood loss in women with and without an intrauterine contraceptive device","volume":"135","author":"Hahn","year":"1979","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/humrep\/del029","article-title":"Preventing copper IUD removals due to side-effects among first time users: placebo-controlled randomized trial to study the effect of prophylactic ibuprofen","volume":"21","author":"Hubacher","year":"2006","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD006034.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3109\/13625187.2014.893425","article-title":"The effect of vitamin B1 on bleeding and spotting in women using an intrauterine device: a double-blind randomised controlled trial","volume":"19","author":"Jafari","year":"2014","journal-title":"European Journal of Contraception & Reproductive Health Care"},{"issue":"4","key":"10.1002\/14651858.CD006034.pub3-BIB0008|cit8","first-page":"216","article-title":"Comparing the effects of tranexamic acid and mefenamic acid in IUD-induced menorrhagia: randomized controlled trial","volume":"1","author":"Kaviani","year":"2013","journal-title":"International Journal of Community Based Nursing and Midwifery"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0020-7292(83)90067-X","article-title":"Dysmenorrhea in women with intrauterine contraceptive device. Treatment with a prostaglandin synthetase inhibitor, naproxen","volume":"21","author":"Lalos","year":"1983","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"9","key":"10.1002\/14651858.CD006034.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1080\/00016340701516777","article-title":"Preventive treatment of intrauterine device-induced menstrual blood loss with tranexamic acid in Chinese women","volume":"86","author":"Lin","year":"2007","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD006034.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"129.e1","DOI":"10.1016\/j.ajog.2011.09.021","article-title":"Naproxen or estradiol for bleeding and spotting with the levonorgestrel intrauterine system: a randomized controlled trial","volume":"206","author":"Madden","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1471-0528.1986.tb07910.x","article-title":"Ibuprofen prevents IUCD-induced increases in menstrual blood loss","volume":"93","author":"Makarainen","year":"1986","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/humrep\/deg449","article-title":"Effectiveness and mechanism of action of desmopressin in the treatment of copper intrauterine device-related menorrhagia: a pilot study","volume":"18","author":"Mercorio","year":"2003","journal-title":"Human Reproduction"},{"issue":"11","key":"10.1002\/14651858.CD006034.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/humrep\/dey296","article-title":"Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control - a randomized controlled trial","volume":"33","author":"Papaikonomou","year":"2018","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0015|cit15","first-page":"101","article-title":"Role of prostaglandins in IUD-associated uterine bleeding - effect of a prostaglandin synthetase inhibitor (ibuprofen)","volume":"58","author":"Roy","year":"1981","journal-title":"Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD006034.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.15296\/ijwhr.2017.32","article-title":"A comparative trial of the efficacy of mefenamic acid and tranexamic acid for treatment of menorrhagia induced by copper T-380A IUD","volume":"5","author":"Saharkhiz","year":"2017","journal-title":"International Journal of Women's Health and Reproduction Sciences"},{"issue":"5","key":"10.1002\/14651858.CD006034.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/AOG.0b013e31828c65d8","article-title":"Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trial","volume":"121","author":"Sordal","year":"2013","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD006034.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/humrep\/dep377","article-title":"Randomized placebo-controlled trial of CDB-2914 in new users of a levonorgestrel-releasing intrauterine system shows only short-lived amelioration of unscheduled bleeding","volume":"25","author":"Warner","year":"2010","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD006034.pub3-BIB0019|cit19","first-page":"245","article-title":"Comparing the effect of mefenamic acid and Vitex agnus on intrauterine device induced bleeding","volume":"2","author":"Yavarikia","year":"2013","journal-title":"Journal of Caring Sciences"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0140-6736(78)91864-0","article-title":"Anti-prostaglandin therapy in prevention of side effects of intrauterine devices","volume":"2","author":"Ylikorkala","year":"1978","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1471-0528.1983.tb06751.x","article-title":"Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices","volume":"90","author":"Ylikorkala","year":"1983","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mefs.2017.09.011","article-title":"The effect of slow versus fast application of vulsellum on pain perception during copper intrauterine device insertion: a randomized controlled trial","volume":"23","author":"Abbas","year":"2018","journal-title":"Middle East Fertility Society Journal"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.contraception.2015.12.006","article-title":"Intrauterine device placement at 3 versus 6 weeks postpartum: a randomized trial","volume":"93","author":"Baldwin","year":"2016","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD006034.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0015-0282(16)43396-0","article-title":"Two modifications of the intrauterine membrane contraceptive device","volume":"30","author":"Bat\u00e1r","year":"1978","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0025|cit25","first-page":"1487","article-title":"Treatment of primary dysmenorrhea and dysmenorrhea because of IUD with PG-synthetase inhibitors","volume":"8","author":"Dreher","year":"1980","journal-title":"Advances in Prostaglandin and Thromboxane Research"},{"issue":"6","key":"10.1002\/14651858.CD006034.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/01.AOG.0000435452.86108.59","article-title":"Characteristics associated with discontinuation of long-acting reversible contraception within the first 6 months of use","volume":"122","author":"Grunloh","year":"2013","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1471-0528.1978.tb15826.x","article-title":"Reduction by mefenamic acid of increased menstrual blood loss associated with intrauterine contraception","volume":"85","author":"Guillebaud","year":"1978","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD006034.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0010-7824(01)00302-X","article-title":"Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years","volume":"65","author":"Hidalgo","year":"2002","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD006034.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijgo.2010.01.015","article-title":"Efficacy of mifepristone in reducing intermenstrual vaginal bleeding in users of the levonorgestrel intrauterine system","volume":"109","author":"Lal","year":"2010","journal-title":"International Journal of Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"399","DOI":"10.5539\/gjhs.v7n4p399","article-title":"Lidocaine-prilocaine cream as analgesia for IUD Insertion: a prospective, randomized, controlled, triple blinded study","volume":"7","author":"Tavakolian","year":"2015","journal-title":"Global Journal of Health Science"},{"issue":"1","key":"10.1002\/14651858.CD006034.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0010-7824(87)90066-7","article-title":"Treatment of increased menstrual blood loss in IUD users","volume":"36","author":"Toppozada","year":"1987","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD006034.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/1471-0528.14445","article-title":"Timing for insertion of levonorgestrel releasing intrauterine system: a randomized controlled trial","volume":"124","author":"Van der Heijden","year":"2017","journal-title":"International Journal of Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0033|cit33","unstructured":"Bayer Healthcare AG International, prospective, double-blind, 3-arm comparative, randomized, placebo-controlled phase IV study on the effect of counseling and either tranexamic acid or mefenamic acid or placebo, on the management of bleeding\/spotting in women using the levonorgestrel-releasing intrauterine system (MIRENA) for contraception clinicaltrials.bayer.com\/study\/?id=15105"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0034|cit34","first-page":"41","article-title":"Action of a prostaglandin synthetase inhibitor on IUD associated uterine bleeding","volume":"14","author":"Di Lieto","year":"1987","journal-title":"Clinical and Experimental Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0035|cit35","first-page":"6958","article-title":"Prophylactic use of prostaglandin synthetase inhibitors in connection with IUD insertion","volume":"160","author":"Jensen","year":"1998","journal-title":"Ugeskrift for Laeger"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0036|cit36","first-page":"226","article-title":"Pain relief with naproxen following insertion of an intrauterine device","volume":"13","author":"Massey","year":"1974","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0037|cit37","first-page":"117","article-title":"Control of IUD-induced bleeding by three non-steroidal anti-inflammatory drugs","volume":"3","author":"Toppozada","year":"1982","journal-title":"Contraceptive Delivery Systems"},{"issue":"7","key":"10.1002\/14651858.CD006034.pub3-BIB0038|cit38","first-page":"496","article-title":"A random control study of indomethacin-containing MYCu intrauterine contraceptive device for 60 months","volume":"93","author":"Wang","year":"2013","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0039|cit39","first-page":"152","article-title":"Randomized multi-center study of baofuxin for treatment of bleeding side-effect induced by IUD","volume":"11","author":"Wu","year":"2000","journal-title":"Reproduction and Contraception"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0040|cit40","first-page":"120","article-title":"Treatment of IUD related menorrhagia by indomethacin","volume":"11","author":"Yarkoni","year":"1984","journal-title":"Clinical and Experimental Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0041|cit41","unstructured":"Bayer HealthCare Pharmaceuticals Mirena: highlights of prescribing information labeling.bayerhealthcare.com\/html\/products\/pi\/Mirena_PI.pdf 2017"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0042|cit42","volume-title":"Statistical Power Analysis in the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"6","key":"10.1002\/14651858.CD006034.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/AOG.0000000000002307","article-title":"Intrauterine device use and cervical cancer risk: a systematic review and meta-analysis","volume":"130","author":"Cortessis","year":"2017","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0044|cit44","unstructured":"Deeks JJ Higgins JP Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD006034.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"50.e1","DOI":"10.1016\/j.ajog.2014.07.025","article-title":"Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction","volume":"212","author":"Diedrich","year":"2014","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/jamapediatrics.2017.0598","article-title":"Long-acting reversible contraception for adolescents: a review","volume":"171","author":"Francis","year":"2017","journal-title":"JAMA Pediatrics"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.contraception.2016.07.001","article-title":"WHO medical eligibility criteria update","volume":"94","author":"Gaffield","year":"2016","journal-title":"Contraception"},{"issue":"5","key":"10.1002\/14651858.CD006034.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.contraception.2012.09.006","article-title":"Treatment of bleeding irregularities in women with copper-containing IUDs: a systematic review","volume":"87","author":"Godfrey","year":"2013","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0049|cit49","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/00365516409060511","article-title":"Determination of menstrual blood loss","volume":"16","author":"Hallberg","year":"1964","journal-title":"Scandinavian Journal of Laboratory Investigation"},{"issue":"4","key":"10.1002\/14651858.CD006034.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.contraception.2015.01.011","article-title":"Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European active surveillance study for intrauterine devices","volume":"91","author":"Heinemann","year":"2015","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD006034.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0010-7824(01)00292-X","article-title":"Vaginal bleeding disturbances and implantable contraceptives","volume":"65","author":"Hickey","year":"2002","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0054|cit54","unstructured":"Higgins JP Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0055|cit55","unstructured":"Higgins JP Li T Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0056|cit56","unstructured":"Higgins JP Eldridge S Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD006034.pub3-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000154.pub3","article-title":"Combined hormonal contraceptives for heavy menstrual bleeding","author":"Lethaby","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD006034.pub3-BIB0059|cit59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007373.pub3","article-title":"Interventions for pain with intrauterine device insertion","author":"Lopez","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006034.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00003495-200363010-00005","article-title":"Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids","volume":"63","author":"Lyseng-Williamson","year":"2002","journal-title":"Drugs"},{"issue":"S1","key":"10.1002\/14651858.CD006034.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1080\/mic.7.S1.S29.S34","article-title":"Biological properties of flavonoids pertaining to inflammation","volume":"7","author":"Manthey","year":"2000","journal-title":"Microcirculation"},{"issue":"7","key":"10.1002\/14651858.CD006034.pub3-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001751.pub3","article-title":"Nonsteroidal anti-inflammatory drugs for dysmenorrhoea","author":"Marjoribanks","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD006034.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/1471-0528.13273","article-title":"The menstrual bleeding questionnaire: development and validation of a comprehensive patient-reported outcome instrument for heavy menstrual bleeding","volume":"122","author":"Matteson","year":"2015","journal-title":"International Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2010.11.011","article-title":"FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"Munro","year":"2011","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD006034.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0010-7824(77)90026-9","article-title":"A rapid method for measuring menstrual blood loss using automatic extraction","volume":"16","author":"Newton","year":"1977","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0066|cit66","unstructured":"Heavy menstrual bleeding: assessment and management www.nice.org.uk\/guidance\/ng88 2018"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1471-0528.2000.tb13225.x","article-title":"Assessment of menstrual blood loss using a pictorial chart: a validation study","volume":"107","author":"Reid","year":"2000","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0069|cit69","unstructured":"Review Manager 5 (RevMan 5) The Cochrane Collaboration 2020"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1089\/jwh.2016.6191","article-title":"Updated guidance for safe and effective use of contraception","volume":"25","author":"Tepper","year":"2016","journal-title":"Journal of Women's Health."},{"key":"10.1002\/14651858.CD006034.pub3-BIB0071|cit71","unstructured":"Department of Economic and Social Affairs Contraceptive use by method 2019: data booklet www.un.org\/development\/desa\/pd\/sites\/www.un.org.development.desa.pd\/files\/files\/documents\/2020\/Jan\/un_2019_contraceptiveusebymethod_databooklet.pdf"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0072|cit72","unstructured":"World Health Organization Medical eligibility criteria for contraceptive use www.who.int\/publications\/i\/item\/9789241549158"},{"key":"10.1002\/14651858.CD006034.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-0773.1994.tb02007.x","article-title":"Prostaglandin synthesis inhibitors in menorrhagia, intrauterine contraceptive device-induced side effects and endometriosis","volume":"75","author":"Ylikorkala","year":"1994","journal-title":"Pharmacology and Toxicology"},{"issue":"4","key":"10.1002\/14651858.CD006034.pub3-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006034.pub2","article-title":"Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use","author":"Grimes","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T16:31:09Z","timestamp":1704213069000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006034.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Fertility Regulation Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":74,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006034.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]}}}